• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Evidence statementsEvidence into recommendations
No evidence was identified.Recommendation was made to allow prescribing of higher doses, combinations, initiation at an earlier age for children at high risk, in exceptional circumstances only and only by specialists. This was to ensure that appropriate treatment is not denied or deferred inappropriately in the absence of evidence.

From: 5, Management (pharmacological treatment)

Cover of Identification and Management of Familial Hypercholesterolaemia (FH)
Identification and Management of Familial Hypercholesterolaemia (FH) [Internet].
NICE Clinical Guidelines, No. 71.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.